Kesäniemi Y A, Lilja M
Department of Internal Medicine, University of Oulu, Finland.
Ann Med. 1991 Aug;23(3):347-51. doi: 10.3109/07853899109148071.
Treatment of hypertension is quite effective in preventing cerebrovascular disease. Morbidity and mortality from coronary heart disease, the major complications of high blood pressure are not, however, generally affected when mild to moderate hypertension is treated with antihypertensive drugs. This is probably owing to the multifactorial nature of atherosclerosis, the main cause of coronary heart disease. For example, dyslipidemias and other risk factors are very common among hypertensive patients. Prevention of coronary heart disease among hypertensive subjects is possible only by intervening in the many contributory risks. Non-pharmacological hypolipidemic treatments such as adequate nutrition and exercise are positive steps in the treatment of all hypertensive patients. The role of various antihypertensive agents should also be carefully considered. The associations between hypertension, several metabolic abnormalities, development of organ complications and various antihypertensive drugs should be explored in detail.
高血压治疗在预防脑血管疾病方面相当有效。然而,高血压的主要并发症冠心病的发病率和死亡率,在使用抗高血压药物治疗轻度至中度高血压时,一般不会受到影响。这可能是由于冠心病的主要病因动脉粥样硬化具有多因素性质。例如,血脂异常和其他危险因素在高血压患者中非常常见。只有通过干预多种促成风险,才有可能预防高血压患者的冠心病。非药物性降血脂治疗,如充足的营养和运动,是所有高血压患者治疗中的积极措施。还应仔细考虑各种抗高血压药物的作用。应详细探讨高血压、几种代谢异常、器官并发症的发展与各种抗高血压药物之间的关联。